DoD Spinal Cord Injury Translational Research Partnership Award

The summary for the DoD Spinal Cord Injury Translational Research Partnership Award Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	DoD Spinal Cord Injury Translational Research Partnership Award
	CFDA Number:	12.420
	CFDA Description:	Military Medical Research and Development
	Federal Agency Name:	Dept of the Army USAMRAA
	Category of Funding Activity:	Science and Technology
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	W81XWH-11-SCIRP-TRPA
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement Grant
	Posted Date:	Jun 01, 2011
	Creation Date:	Jun 01, 2011
	Original Closing Date for Applications:	Dec 01, 2011
	Current Closing Date for Applications:	Dec 01, 2011
	Archive Date:	Dec 31, 2011
	Expected Number of Awards:	2
	Estimated Total Program Funding:	2,400,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Information not provided
Grant Description: The SCIRP Translational Research Partnership Award (TRPA) mechanism was first offered in FY09. Since then, 22 TRPA applications have been received, and 8 have been recommended for funding. The intent of the TRPA is to promote multi-institutional, multidisciplinary partnerships among clinicians and basic scientists that accelerate the movement of promising ideas in spinal cord injury research into clinical applications. This award is intended to support both new and established scientists across a broad spectrum of disciplines in research projects that are likely to have a major impact on spinal cord injury research. The TRPA supports the development of translational research partnerships among two or three independent investigators (known as partners). Applications should address one or more of the FY11 SCIRP Areas of Encouragement or justify the applicability of the research to the spinal cord injured military and/or veteran population. At least one partner must be a clinician, and at least one partner must have experience in spinal cord injury basic research. A clinician is defined as an individual who is credentialed (possesses the necessary degrees, licenses, and other certifications) as a care provider in any relevant capacity at the institution of record. Biosketches should include appropriate documentation of credentials. It should be clear that all partners have substantial intellectual input into the design of the research project. A proposed project in which one of the partners merely provides tissue samples or access to patients will not meet the intent of this mechanism. Observations that drive a research idea may be derived from a basic discovery, population-based studies, or a clinicians firsthand knowledge of patients and preliminary data. While the ultimate goal of translational research is to move an observation forward into clinical application, members of the partnership should view translational research as a two-way continuum between bench and bedside. Developing the research plan must involve a reciprocal flow of ideas and information within the partnership. Developmental pathways for translational research that may be useful for designing translational research studies for support under this mechanism may be found at (http://www.cancer.gov/aboutnci/trwg/Pathways-to-Clinical-Goals). Applications must include preliminary data relevant to SCI and the proposed project. Important aspects of the TRPA are as follows: 1. Translational: The application should provide evidence for the reciprocal transfer of ideas between basic and clinical science in developing and implementing the research plan. 2. Partnership: The success of the project depends on the unique disciplines, skills, and contributions of each partner. Of the two to three partners, at least one must be a clinician, and at least one must have experience in SCI basic research. 3. Multi-institutional: At least two distinct institutions must be involved. 4. Impact: The proposed research should have a significant impact on the concepts or methods that are likely to accelerate the movement of promising ideas in spinal cord injury research into clinical applications. Research involving human subjects and human anatomical substances is permitted; however, clinical trials are NOT ALLOWED under this funding opportunity. A clinical trial is defined as a prospective accrual of human subjects where an intervention (e.g., device, drug, biologic, surgical procedure, rehabilitative modality, behavioral intervention, or other) is tested on a human subject for a measurable outcome with respect to exploratory information, safety, effectiveness, and/or efficacy. This outcome represents a direct effect on the human subject of that intervention or interaction. The SCIRP encourages clinical trials with a focus on rehabilitation through the FY11 SCIRP Clinical Trial Award Rehabilitation mechanism (Funding Opportunity Number: W81XWH-11-SCIRP-CTA). Use of Human Subjects and Human Anatomical Substances: All DOD-funded research involving new and ongoing research with human subjects and human anatomical substances must be reviewed and approved by the US Army Medical Research and Materiel Command (USAMRMC) Office of Research Protections (ORP), Human Research Protection Office (HRPO), in addition to the local Institutional Review Board (IRB) of record. Local IRB approval at the time of submission is NOT required. The HRPO is mandated to comply with specific laws and directives governing all research involving human subjects that is supported by the DOD. These laws and directives are rigorous and detailed, and will require information in addition to that supplied to the local IRB. Allow a minimum of 4 months for regulatory review and approval processes. Refer to the General Application Instructions, Appendix 5, for more information.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: 301-682-5507

CDMRP Help Desk [help@cdmrp.org]
Similar Government Grants: • DOD FY11 Breast Cancer Research Program Clinical Translational Research Award; • DoD Peer Reviewed Orthopaedic Technology Development Award; • DoD Peer Reviewed Orthopaedic Translational Research Partnership Award; • DoD Peer Reviewed Orthopaedic Clinical Trial Award; • DoD Post-Traumatic Stress Disorder In-Home Therapy Clinical Trial Award; • FY2006 Deployed War Fighter Protection Research Program; • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)Concept Awa...; • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) Innovator ...; • Department of Defense (DOD) FY04 Breast Cancer Research Program (BCRP) Concept Award (CA); • Department of Defense Fiscal Year 2004 Breast Cancer Center of Excellence Award (COE)